Site icon Medical Market Report

Breast Cancer Screening Market is expected to grow at a significant CAGR of 8.7%

Market Overview

The breast cancer screening market encompasses all products and services designed to detect breast cancer in women. It includes screening tests such as mammography, ultrasound, magnetic resonance imaging (MRI), and other imaging modalities; additionally, it offers diagnostic tests like biopsies and other laboratory procedures. estimates the global breast cancer screening market size to be valued at USD 5.8 billion in 2022 and projected to expand at a compound annual growth rate (CAGR) of 8.7% from 2022-2032, due primarily to rising incidence rates worldwide and rising adoption of early detection and screening programs, increasing awareness among women about screening procedures, and advances in imaging technologies. These factors are all contributing factors to market expansion.

Geographically, North America dominates the global breast cancer screening market due to its high prevalence of cancer and established healthcare infrastructure. However, Asia Pacific is projected to experience the highest compound annual growth rate during the forecast period due to increasing awareness about screening procedures as well as improved healthcare facilities in that region.

The breast cancer screening market is highly competitive and fragmented, with several key players operating within it. Hologic, Inc., Siemens Healthineers, GE Healthcare, Fujifilm Holdings Corporation, and Koninklijke Philips N.V are some of the key companies operating within this space; these companies are investing heavily in product development and innovation to stay ahead of competitors within this space.

Key Takeaways

To get a detailed analysis of other segments, Request For Sample Report:


Key Market Segments



Key Market Players




Recent Developments

Contact our Market Specialist Team

Global Business Development Teams – (Powered By Prudour Pvt. Ltd.)

Send Email:

Address: 420 Lexington Avenue, Suite 300, New York City, NY 10170, United States

Tel: +1 718 618 4351

Exit mobile version